| # | Drug | Count |
|---|---|---|
| 0 | SILDENAFIL CITRATE | 46 |
| 1 | EPOPROSTENOL | 45 |
| 2 | AMBRISENTAN | 41 |
| 3 | TADALAFIL | 40 |
| 4 | TREPROSTINIL | 40 |
| 5 | MACITENTAN | 34 |
| 6 | FUROSEMIDE | 29 |
| 7 | BOSENTAN | 28 |
| 8 | SILDENAFIL | 26 |
| 9 | WARFARIN | 24 |
| # | Drug | Count | Frequency |
|---|---|---|---|
| 0 | PROVIDONE IODINE | 1 | 0.1250 |
| 1 | OLIVE OIL AND SOYBEAN OIL | 1 | 0.0312 |
| 2 | MILRINONE LACTATE | 1 | 0.0036 |
| 3 | EPOPROSTENOL | 45 | 0.0034 |
| 4 | LUMASIRAN | 1 | 0.0026 |
| 5 | ISRADIPINE | 1 | 0.0018 |
| 6 | STERILE WATER FOR INJECTION | 7 | 0.0013 |
| 7 | DIFLUPREDNATE OPHTHALMIC | 1 | 0.0011 |
| 8 | TRAMADOL HYDROCHLORIDE AND ACETAMINOPHEN | 1 | 0.0011 |
| 9 | OXACILLIN SODIUM | 1 | 0.0009 |
| # | Drug class | Count |
|---|---|---|
| 0 | Prostacycline Vasodilator [EPC] | 78 |
| 1 | Endothelin Receptor Antagonist [EPC] | 73 |
| 2 | Phosphodiesterase 5 Inhibitor [EPC] | 54 |
| 3 | Loop Diuretic [EPC] | 30 |
| 4 | Corticosteroid [EPC] | 23 |
| 5 | Aldosterone Antagonist [EPC] | 20 |
| 6 | Factor Xa Inhibitor [EPC] | 19 |
| 7 | Nonsteroidal Anti-inflammatory Drug [EPC] | 18 |
| 8 | Osmotic Laxative [EPC] | 18 |
| 9 | Erythropoiesis-stimulating Agent [EPC] | 16 |
| # | Drug class | Count | Frequency |
|---|---|---|---|
| 0 | Antiseptic [EPC] | 3 | 0.0007 |
| 1 | Hydrolytic Lysosomal Glycogen-specific Enzyme [EPC] | 2 | 0.0006 |
| 2 | Prostacycline Vasodilator [EPC] | 78 | 0.0006 |
| 3 | Prostacyclin Receptor Agonist [EPC] | 12 | 0.0005 |
| 4 | Phosphodiesterase 5 Inhibitor [EPC] | 54 | 0.0004 |
| 5 | Lipid Emulsion [EPC] | 1 | 0.0004 |
| 6 | Endothelin Receptor Antagonist [EPC] | 73 | 0.0004 |
| 7 | Soluble Guanylate Cyclase Stimulator [EPC] | 12 | 0.0004 |
| 8 | Hydrolytic Lysosomal Neutral Glycosphingolipid-specific Enzyme [EPC] | 3 | 0.0003 |
| 9 | Provitamin D2 Compound [EPC] | 9 | 0.0003 |